CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Increasing prevalence of chronic and infectitous diseases
3.4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness
3.4.1.3 Technological Advancements and adoption of home-based point of care devices
3.4.1.4 Increasing healthcare expenditures worldwide

3.4.2 Restraints

3.4.2.1 Stringent regulatory requirements for the approval and commercialization of point of care diagnostic devices
3.4.2.2 Inadequate reimbursement policies for point of care diagnostic devices

3.4.3 Opportunities

3.4.3.1 Developing economies offer lucarative growth opportunities

CHAPTER 4 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT

4.1 Overview
4.2 Glucose monitoring kits

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Infectious diseases testing kits

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Hepatitis testing kits

4.3.4.1 Market size and forecast

4.3.5 HIV testing kits

4.3.5.1 Market size and forecast

4.3.6 Respiratory infections testing kits

4.3.6.1 Market size and forecast

4.3.7 Influenza testing kits

4.3.7.1 Market size and forecast

4.3.8 Healthcare-associated infections (HAIs) testing kits

4.3.8.1 Market size and forecast

4.3.9 Sexually-transmitted diseases (STDs) testing kits

4.3.9.1 Market size and forecast

4.3.10 Other infectious disease point of care testing kits

4.3.10.1 Market size and forecast

4.4 Pregnancy and fertility testing kits

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Pregnancy testing kits

4.4.4.1 Market size and forecast

4.4.5 Fertility testing kits

4.4.5.1 Market size and forecast

4.5 Hematology testing kits

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

4.6 Cardiometabolic monitoring kits

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Cardiac markers test kits

4.6.4.1 Market size and forecast

4.6.5 HbA1c testing kits

4.6.5.1 Market size and forecast

4.6.6 Electrolytes and metabolites testing kits

4.6.6.1 Market size and forecast

4.7 Urinalysis testing devices

4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast

4.8 Coagulation monitoring kits

4.8.1 Key market trends
4.8.2 Key growth factors and opportunities
4.8.3 Market size and forecast

4.9 Tumor or cancer markers testing devices

4.9.1 Key market trends
4.9.2 Key growth factors and opportunities
4.9.3 Market size and forecast

4.10 Cholesterol testing strips

4.10.1 Key market trends
4.10.2 Key growth factors and opportunities
4.10.3 Market size and forecast

4.11 Drugs of abuse testing kits

4.11.1 Key market trends
4.11.2 Key growth factors and opportunities
4.11.3 Market size and forecast

4.12 Fecal occult testing kits

4.12.1 Key market trends
4.12.2 Key growth factors and opportunities
4.12.3 Market size and forecast

4.13 Other point of care testing devices

4.13.1 Key market trends
4.13.1 Key growth factors and opportunities
4.13.2 Market size and forecast

CHAPTER 5 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY END USER

5.1 Overview

5.1.1 Market size and forecast

5.2 Professional diagnostic centers

5.2.1 Market size and forecast
5.2.2 Hospitals/critical care centers

5.2.2.1 Market size and forecast

5.2.3 Outpatient healthcare settings

5.2.3.1 Market size and forecast

5.2.4 Ambulatory care settings

5.2.4.1 Market size and forecast

5.3 Research laboratories

5.3.1 Market size and forecast

5.4 Home

5.4.1 Market size and forecast

5.5 Others

5.5.1 Market size and forecast

CHAPTER 6 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION

6.1 Introduction
6.2 Prescription based testing devices

6.2.1 Market size and forecast

6.3 Over-the-counter (OTC) testing devices

6.3.1 Market size and forecast

CHAPTER 7 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S. market size and forecast
7.2.5 Canada market size and forecast
7.2.6 Mexico market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany market size and forecast
7.3.5 France market size and forecast
7.3.6 U.K.

7.3.6.1 Market size and forecast

7.3.7 Italy

7.3.7.1 Market size and forecast

7.3.8 Spain

7.3.8.1 Market size and forecast

7.3.9 Rest of Europe

7.3.9.1 Market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan

7.4.4.1 Market size and forecast

7.4.5 China

7.4.5.1 Market size and forecast

7.4.6 India

7.4.6.1 Market size and forecast

7.4.7 Rest of Asia-Pacific

7.4.7.1 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil

7.5.4.1 Market size and forecast

7.5.5 UAE

7.5.5.1 Market size and forecast

7.5.6 Rest of LAMEA

7.5.6.1 Market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1 Abbott Laboratories

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves & developments

8.2 Siemens AG

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves & developments

8.3 F. Hoffmann-La Roche Ltd

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves & developments

8.4 Sinocare Inc.

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Business performance
8.4.4 Key strategic moves & developments

8.5 Johnson & Johnson

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Business performance
8.5.4 Key strategic moves & developments

8.6 Sysmex Corporation

8.6.1 Company overview
8.6.2 Operating product categories
8.6.3 Business performance
8.6.4 Key strategic moves & developments

8.7 Nova Biomedical

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves & developments

8.8 Danaher Corporation

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves & developments

8.9 Becton Dickinson and Company

8.9.1 Company overview
8.9.2 Business performance
8.9.3 Key strategies and development

8.10 bioMrieux SA

8.10.1 Company overview
8.10.2 bioMerieux - COMPANY SNAPSHOT
8.10.3 Operating business segments
8.10.4 Business performance
8.10.5 Key strategic moves & developments

8.11 Bio-Rad Laboratories

8.11.1 Company overview
8.11.2 Operating business segments
8.11.3 Business performance
8.11.4 Key strategic moves & developments